Skinvisible Pharmaceuticals, Inc.
(OTCBB: SKVI)

Dear Members,

One of Skinvisible’s greatest strengths is its patent portfolio. Protecting its polymer delivery system is critical to the Company, and they have patents in the United States, Canada and in many key countries of the world. Let’s take a look at those.

Here is a current list of patents that have already been granted:

Patents Granted
United States Patents Granted – Skinvisible  United States Patent No.:   8,318,818 Granted:   November 27, 2012 (1420 day extension) Topical composition, topical composition precursor, and methods for manufacturing and using.United States Patent No.:   7,674,471 Granted:   Granted: March 9, 2010 (921 day extension) Topical composition, topical composition precursor, and methods for manufacturing and using. United States Patent No.:   6,756,059 Granted:   June 29, 2004 Topical composition, topical composition precursor, and methods for manufacturing and using. United States Invisicare Product Patents Granted United States Patent No.:   8,299,122 Granted:   October 30, 2012 Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition. United States Patent No.:   8,128,913 Granted:   March 6, 2012 Sunscreen composition with enhanced UV-A absorber stability and methods. United States Patent No.:   6,582,683 Granted:   June 24, 2003 Dermal barrier composition.	International Patents Granted  India Patent Granted:  July 26, 2007 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.Australia Patent Granted:  June 3, 2008 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. Japan Patent Granted:  October 31, 2008 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. China Patent Granted:  July 1, 2009 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. Korea Patent Granted:  February 9, 2010 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. Hong Kong Patent Granted:  July 27, 2010 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. Canada Patent Granted:  February 22, 2011 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using. European Patent(4) Granted:  September, 2011 Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
This list does not include pending patent application.  Patents are granted for 20 years from application date and may be extended by the Patent Office beyond 20 years.

 

The reason this is so critical is that although they have a lot of great products at market and the potential to deliver even more, their difference is the polymer delivery system. That must be protected. That is what could even cause a big pharma to step in and buy the technology (or even the Company) for huge dollars one day.

COMING UP ON FRIDAY: 

A look at the products in more detail!

 

 

MORE INFORMATION ON SKINVISIBLE:

Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI)

 

CORPORATE CONTACT:

Doreen McMorran
Skinvisible Pharmaceuticals, Inc.
Phone: 702-433-7154
Email: [email protected]

ON THE WEB:

Skinvisible.com

Invisicare.com

 

 

Disclosures: We hold no shares of Skinvisible stock, and are not contracted to receive shares during the present period of coverage. We do not anticipate receiving shares either from the company or any third party.  Had we had shares, we avoid all potential conflicts of interest, as we never sell shares into the open market during an active market awareness or investor relations program. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.  StockGuru is retained by Skinvisible for consulting purposes and investor awareness. We have received a total of six thousand two hundred dollars in payments. Previously for coverage in 2009, we were compensated and once held five hundred thousand shares of 144 restricted stock. We anticipate receiving up to six thousand dollars potentially over the next 180 days. We do not anticipate receiving shares of any kind, restricted or otherwise. StockGuru is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 – (469) 252-3030.